VA long beach lenalidomide do
Active Awarded Last action
- Contract number
- 36C26226N0306
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,090,219
Award facts
- Contract value 100% obligated
- $1,090,219.00 Current and potential, with all options
- Completion date 77% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Boca Raton, FL 33432, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$2,600,000 | |
| Original award | $3,690,219 |
About this award
Veterans Integrated Service Network 22 issued a BPA call to Exelan Pharmaceuticals Inc. for lenalidomide products with a ceiling value of $1,090,219, awarded January 15, 2026, with ultimate completion by January 14, 2027.
The call is issued under a Blanket Purchase Agreement for Lenalidomide products valued at $21.17 million. Performance occurs at Boca Raton, Florida. The call decreases and updates pricing on the existing BPA framework. Exelan Pharmaceuticals, a for-profit pharmaceutical manufacturing and distribution company headquartered in Boca Raton, performs substantially all work at its facility or designated delivery locations. The contract is priced firm fixed price with no set-aside designation.
Quick answers
Who was awarded contract 36C26226N0306?
36C26226N0306 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on January 15, 2026.
How much is contract 36C26226N0306 worth?
The government has obligated $1,090,219 on 36C26226N0306.
Is contract 36C26226N0306 an order under another contract?
Yes. 36C26226N0306 is a BPA call under 36F79720D0227-36C26226A0006, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26226N0306 competed?
The extent of competition for 36C26226N0306 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award